BMY
USDBristol-Myers Squibb Company Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$46.770
Kõrge
$47.420
Madal
$46.650
Maht
12.61M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
96.0B
Tööstusharu
Drug Manufacturers - General
Riik
United States
Kauplemisstatistika
Keskmine maht
14.87M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Seotud uudised
Bristol Myers, Pfizer to sell blood thinner Eliquis directly to patients
US drugmakers Bristol Myers and Pfizer said on Thursday that they will make their blood thinner, Eliquis, available directly to cash-paying patients at discounted rate through a new program.
Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option
Eliquis 360 Support Program Now Offers Eliquis to Cash-Paying Patients at More than 40% Discount to Current List Price The Bristol Myers Squibb-Pfizer (NYSE:BMY) – (NYSE:PFE) Alliance today announced a new
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Trump's "big beautiful" bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of digital health funding this year.
U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb's Cell Therapy Labels
Label updates reflect growing body of real-world evidence and regulatory confidence in the safety profile of the class of CD19- and BCMA-directed autologous CAR T cell therapies, reinforcing efforts to increase
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.